Cargando…

Risedronate inhibits human osteosarcoma cell invasion

BACKGROUND: Osteosarcoma is a highly malignant bone tumor and is the most commonly encountered malignant bone tumor in children and adolescents. Furthermore, significant numbers of patients eventually develop pulmonary metastases and succumb to the disease even after conventional multi-agent chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xin, Zeng Feng, Kim, Yang Kyung, Jung, Sung Taek
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729740/ https://www.ncbi.nlm.nih.gov/pubmed/19624845 http://dx.doi.org/10.1186/1756-9966-28-105

Ejemplares similares

Chondroblastic Osteosarcoma of the Mandible in a Patient on Risedronate: A Rare Case of Neoadjuvant Chemotherapy Failure
por: Boussouni, Soufiane, et al.
Publicado: (2021)

Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro/in vivo characterization
por: Jung, Il-Woo, et al.
Publicado: (2014)

Anti-fracture Efficacy of Monthly Risedronate Compared with That of Weekly Risedronate in Postmenopausal Korean Women with Osteoporosis: A Nationwide Cohort Study
por: Cho, Yong Ho, et al.
Publicado: (2020)

Effects of Risedronate on Osteoarthritis of the Knee
por: Iwamoto, Jun, et al.
Publicado: (2010)

Synergistic Antitumor Interaction of Risedronate Sodium and Standard Anticancer Agents in Canine (D-17) and Human Osteosarcoma (U-2 OS) Cell Lines
por: Poradowski, Dominik, et al.
Publicado: (2022)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
por: Peralta, Ma. Florencia, et al.
Publicado: (2021)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

In Vitro Studies on the Influence of Meloxicam on Cytotoxic Activity Induced by Risedronate Sodium in Canine (D-17) and Human (U-2 OS) Osteosarcoma Cell Lines
por: Poradowski, Dominik, et al.
Publicado: (2021)

Risedronate-loaded aerogel scaffolds for bone regeneration
por: El-Wakil, Nahla, et al.
Publicado: (2022)

Crystallization Products of Risedronate with Carbohydrates and Their Substituted Derivatives (†)
por: Kos, Jiri, et al.
Publicado: (2011)

Preparation of Risedronate Nanoparticles by Solvent Evaporation Technique
por: Vaculikova, Eliska, et al.
Publicado: (2014)

Effect of risedronate on bone loss at discontinuation of denosumab
por: Laroche, Michel, et al.
Publicado: (2020)

An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate
por: Kleinermans, Diane, et al.
Publicado: (2022)

Inhibition of Aurora-B suppresses osteosarcoma cell migration and invasion
por: ZHU, XIAO PING, et al.
Publicado: (2014)

Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials
por: Shigematsu, Takashi, et al.
Publicado: (2017)

MiR-133b Is Down-Regulated in Human Osteosarcoma and Inhibits Osteosarcoma Cells Proliferation, Migration and Invasion, and Promotes Apoptosis
por: Zhao, Huafu, et al.
Publicado: (2013)

Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
por: Asada, Yohei, et al.
Publicado: (2019)

Effects of risedronate on fracture risk in postmenopausal women with osteopenia
por: Siris, E. S., et al.
Publicado: (2007)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
por: Bobba, Raja, et al.
Publicado: (2007)

MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells
por: Ruan, Wen-Dong, et al.
Publicado: (2016)

Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA
por: Eisman, John A., et al.
Publicado: (2023)

Knockdown of DDX46 Inhibits the Invasion and Tumorigenesis in Osteosarcoma Cells
por: Jiang, Feng, et al.
Publicado: (2017)

Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
por: Kamimura, Mikio, et al.
Publicado: (2016)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Masud, Tahir, et al.
Publicado: (2009)

The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation
por: Valenti, Maria Teresa, et al.
Publicado: (2010)

Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis
por: Permuy, María, et al.
Publicado: (2014)

Overexpression of FES might inhibit cell proliferation, migration, and invasion of osteosarcoma cells
por: Zhao, Yang, et al.
Publicado: (2020)

Knockdown of SALL4 Inhibits Proliferation, Migration, and Invasion in Osteosarcoma Cells
por: Zhang, Dengfeng, et al.
Publicado: (2017)

Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate
por: Matsumoto, Y., et al.
Publicado: (2009)

Risedronate’s Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis
por: Gates, Brian J., et al.
Publicado: (2012)

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole
por: Monda, Vincenzo, et al.
Publicado: (2017)

SUN-LB66 Oral Risedronate Treatment in Children With Osteogenesis Imperfecta
por: Nguyen, Antoine T, et al.
Publicado: (2020)

Histomorphometric Effects of 2% Risedronate Gel on Calvarial Bone Defects in Rabbits
por: Aghayan, Shabnam, et al.
Publicado: (2021)

KLF8 knockdown suppresses proliferation and invasion in human osteosarcoma cells
por: LIN, FENG, et al.
Publicado: (2014)

Down-Regulation of Ribosomal Protein RPS21 Inhibits Invasive Behavior of Osteosarcoma Cells Through the Inactivation of MAPK Pathway
por: Wang, Tao, et al.
Publicado: (2020)

MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2
por: Xie, Xi, et al.
Publicado: (2017)

Can locally applied risedronate be an effective agent when combined with xenografts? An animal study
por: Özer, Taha, et al.
Publicado: (2023)

Metabolic activities affect femur and lumbar vertebrae remodeling, and anti-resorptive risedronate disturbs femoral cortical bone remodeling
por: Kim, Mi Yeong, et al.
Publicado: (2021)

Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance
por: Ke, Cheng‐hui, et al.
Publicado: (2021)

Risedronate Effects on the In Vivo Bioactive Glass Behavior: Nuclear Magnetic Resonance and Histopathological Studies
por: Mosbahi, Siwar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r7dv9av24uf56hgjitg5365obc